New therapies in chronic prostatitis

Abstract

The optimal management of category III prostatitis (chronic pelvic pain syndrome) is not known. Conventional therapy usually consists of prolonged courses of antibiotics; however, clinical trials have never shown their efficacy. Newer therapies with some evidence for efficacy include alpha-blockers, anti-inflammatory phytotherapy (quercetin, bee pollen), physiotherapy, neuroleptics, and others with unique actions such as antinanobacterial treatment. A stepwise approach involving multiple treatment modalities is often successful for patients with this common and frustrating condition.

Differential performance of honey bee colonies selected for bee-pollen production through instrumental insemination and free-mating technique

“…Zootec., v.68, n.5, p. [1369][1370][1371][1372][1373]2016 been incorporated into human diets. Its use has also been encouraged for potential benefits against diseases, especially prostatic cancer (Habib et al, 1990;Zhang et al, 1995;Hana et al, 2007;Wu and Lou, 2007;Wang et al, 2015), chronic prostatitis (Dhar and Shoskes, 2007;Buck et al, 1989), and prostatic hyperplasia (Xu et al, 2008). Athletes, ever chasing improved performance, are also encouraged to consume bee-pollen on a regular basis (Maughan and Evans, 1982).…”